These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

791 related articles for article (PubMed ID: 33152946)

  • 1. Prolyl oligopeptidase inhibition by KYP-2407 increases alpha-synuclein fibril degradation in neuron-like cells.
    Rostami J; Jäntti M; Cui H; Rinne MK; Kukkonen JP; Falk A; Erlandsson A; Myöhänen T
    Biomed Pharmacother; 2020 Nov; 131():110788. PubMed ID: 33152946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of prolyl oligopeptidase inhibitors on alpha-synuclein aggregation and autophagy cannot be predicted by their inhibitory efficacy.
    Kilpeläinen TP; Hellinen L; Vrijdag J; Yan X; Svarcbahs R; Vellonen KS; Lambeir AM; Huttunen H; Urtti A; Wallen EAA; Myöhänen TT
    Biomed Pharmacother; 2020 Aug; 128():110253. PubMed ID: 32447211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The beneficial effect of a prolyl oligopeptidase inhibitor, KYP-2047, on alpha-synuclein clearance and autophagy in A30P transgenic mouse.
    Savolainen MH; Richie CT; Harvey BK; Männistö PT; Maguire-Zeiss KA; Myöhänen TT
    Neurobiol Dis; 2014 Aug; 68():1-15. PubMed ID: 24746855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Prolyl Oligopeptidase Restores Spontaneous Motor Behavior in the α-Synuclein Virus Vector-Based Parkinson's Disease Mouse Model by Decreasing α-Synuclein Oligomeric Species in Mouse Brain.
    Svarcbahs R; Julku UH; Myöhänen TT
    J Neurosci; 2016 Dec; 36(49):12485-12497. PubMed ID: 27927963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prolyl oligopeptidase inhibitor, KYP-2047, reduces α-synuclein protein levels and aggregates in cellular and animal models of Parkinson's disease.
    Myöhänen TT; Hannula MJ; Van Elzen R; Gerard M; Van Der Veken P; García-Horsman JA; Baekelandt V; Männistö PT; Lambeir AM
    Br J Pharmacol; 2012 Jun; 166(3):1097-113. PubMed ID: 22233220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolyl oligopeptidase inhibition attenuates the toxicity of a proteasomal inhibitor, lactacystin, in the alpha-synuclein overexpressing cell culture.
    Myöhänen TT; Norrbacka S; Savolainen MH
    Neurosci Lett; 2017 Jan; 636():83-89. PubMed ID: 27818354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Removal of proteinase K resistant αSyn species does not correlate with cell survival in a virus vector-based Parkinson's disease mouse model.
    Eteläinen TS; Kilpeläinen TP; Ignatius A; Auno S; De Lorenzo F; Uhari-Väänänen JK; Julku UH; Myöhänen TT
    Neuropharmacology; 2022 Nov; 218():109213. PubMed ID: 35964686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolyl oligopeptidase enhances α-synuclein dimerization via direct protein-protein interaction.
    Savolainen MH; Yan X; Myöhänen TT; Huttunen HJ
    J Biol Chem; 2015 Feb; 290(8):5117-5126. PubMed ID: 25555914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of prolyl oligopeptidase increases the survival of alpha-synuclein overexpressing cells after rotenone exposure by reducing alpha-synuclein oligomers.
    Dokleja L; Hannula MJ; Myöhänen TT
    Neurosci Lett; 2014 Nov; 583():37-42. PubMed ID: 25240592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolyl oligopeptidase acts as a link between chaperone-mediated autophagy and macroautophagy.
    Cui H; Norrbacka S; Myöhänen TT
    Biochem Pharmacol; 2022 Mar; 197():114899. PubMed ID: 34968496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolyl oligopeptidase inhibition activates autophagy via protein phosphatase 2A.
    Svarcbahs R; Jäntti M; Kilpeläinen T; Julku UH; Urvas L; Kivioja S; Norrbacka S; Myöhänen TT
    Pharmacol Res; 2020 Jan; 151():104558. PubMed ID: 31759088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolyl oligopeptidase inhibition reduces alpha-synuclein aggregation in a cellular model of multiple system atrophy.
    Cui H; Kilpeläinen T; Zouzoula L; Auno S; Trontti K; Kurvonen S; Norrbacka S; Hovatta I; Jensen PH; Myöhänen TT
    J Cell Mol Med; 2021 Oct; 25(20):9634-9646. PubMed ID: 34486218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein.
    Wang B; Underwood R; Kamath A; Britain C; McFerrin MB; McLean PJ; Volpicelli-Daley LA; Whitaker RH; Placzek WJ; Becker K; Ma J; Yacoubian TA
    J Neurosci; 2018 Sep; 38(38):8211-8232. PubMed ID: 30093536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trehalose does not improve neuronal survival on exposure to alpha-synuclein pre-formed fibrils.
    Redmann M; Wani WY; Volpicelli-Daley L; Darley-Usmar V; Zhang J
    Redox Biol; 2017 Apr; 11():429-437. PubMed ID: 28068606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcellular propagation of fibrillar α-synuclein from enteroendocrine to neuronal cells requires cell-to-cell contact and is Rab35-dependent.
    Rodrigues PV; de Godoy JVP; Bosque BP; Amorim Neto DP; Tostes K; Palameta S; Garcia-Rosa S; Tonoli CCC; de Carvalho HF; de Castro Fonseca M
    Sci Rep; 2022 Mar; 12(1):4168. PubMed ID: 35264710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. α-Synuclein (αSyn) Preformed Fibrils Induce Endogenous αSyn Aggregation, Compromise Synaptic Activity and Enhance Synapse Loss in Cultured Excitatory Hippocampal Neurons.
    Wu Q; Takano H; Riddle DM; Trojanowski JQ; Coulter DA; Lee VM
    J Neurosci; 2019 Jun; 39(26):5080-5094. PubMed ID: 31036761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolyl oligopeptidase inhibition reduces oxidative stress via reducing NADPH oxidase activity by activating protein phosphatase 2A.
    Eteläinen T; Kulmala V; Svarcbahs R; Jäntti M; Myöhänen TT
    Free Radic Biol Med; 2021 Jun; 169():14-23. PubMed ID: 33838285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 14-3-3 mitigates alpha-synuclein aggregation and toxicity in the in vivo preformed fibril model.
    Underwood R; Gannon M; Pathak A; Kapa N; Chandra S; Klop A; Yacoubian TA
    Acta Neuropathol Commun; 2021 Jan; 9(1):13. PubMed ID: 33413679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crosstalk between astrocytes and microglia results in increased degradation of α-synuclein and amyloid-β aggregates.
    Rostami J; Mothes T; Kolahdouzan M; Eriksson O; Moslem M; Bergström J; Ingelsson M; O'Callaghan P; Healy LM; Falk A; Erlandsson A
    J Neuroinflammation; 2021 Jun; 18(1):124. PubMed ID: 34082772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of the p53-p21 pathway by G2019S LRRK2 contributes to the cellular senescence and accumulation of α-synuclein.
    Ho DH; Seol W; Son I
    Cell Cycle; 2019 Feb; 18(4):467-475. PubMed ID: 30712480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.